Qube Research & Technologies LTD Selecta Biosciences Inc Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $435,829 - $716,275	378,982 Added 565.24%	446,030 $619,000
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.6 $6,757 - $11,262	7,039 Added 11.73%	67,048 $75,000
Q3 2022 Nov 14, 2022	SELL	$1.33 - $2.6 $65,752 - $128,538	-49,438 Reduced 45.17%	60,009 $98,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $73,329 - $153,225	109,447 New	109,447 $143,000
Q1 2022 May 09, 2022	SELL	$1.23 - $3.31 $81,369 - $218,969	-66,154 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$2.89 - $4.43 $191,185 - $293,062	66,154 New	66,154 $216,000
Q2 2021 Aug 13, 2021	SELL	$2.82 - $5.01 $94,224 - $167,399	-33,413 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.92 - $5.07 $97,565 - $169,403	33,413 New	33,413 $151,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.